Track Echo IQ Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Echo IQ Limited EIQ.AX · Stock Open Echo IQ Limited in new tab

1.65 AUD
EPS
-0.03
P/B
58.89
ROE
-115.20
Beta
0.19
Target Price
1.69 AUD
Loading chart...
Key Metrics
Earnings dateAug. 27, 2026
EPS-0.03
Book Value0.03
Price to Book58.89
% Insiders30.895%
Growth
Revenue Growth-0.10%
Estimates
Forward P/E-217.81
Forward EPS-0.01
Target Mean Price1.69

DCF Valuation

Tweak assumptions to recompute fair value for Echo IQ Limited (EIQ.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Echo IQ Limited Logo Echo IQ Limited Analysis (EIQ.AX)

Australia Technology Official Website Stock

Is Echo IQ Limited a good investment? Echo IQ Limited (EIQ.AX) is currently trading at 1.65 AUD. Market analysts have a consensus price target of 1.69 AUD. This suggests a potential upside from current levels.

Earnings Schedule: Echo IQ Limited is expected to release its next earnings report on Aug. 27, 2026. The market consensus estimate for Forward EPS is -0.01.

Investor FAQ

Does Echo IQ Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is Echo IQ Limited?

Echo IQ Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 27, 2026. The company currently has a trailing EPS of -0.03.

Company Profile

Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company has a research collaboration with Mayo Clinic to evaluate echo IQ's proprietary artificial intelligence platform for cardiac risk stratification in oncology patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is headquartered in Sydney, Australia.

Exchange Ticker
ASX EIQ.AX
Trades
Dividend History paid per year (AUD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Aug. 13, 2019 0.100000
Aug. 12, 2019 0.100000
Dec. 9, 2015 1.060000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion